Plagne R, Chollet P, Legros M, Cure H, Ferrière J P, Bignon Y J
Service d'oncologie médicale, centre Jean-Perrin, Clermont-Ferrand.
Rev Prat. 1990 Apr 1;40(10):905-8.
Adjuvant medical treatments (chemotherapy or endocrine therapy) are now used in the vast majority of women with breast cancer. They delay recurrences and reduce their number, the increase in survival being particularly marked in limited forms. They also reinforce local treatment and increase the possibility of breast conservation. Their indications can be better determined by precise analysis of prognostic factors, notably tumoral cells.
辅助性医学治疗（化疗或内分泌治疗）目前在绝大多数乳腺癌女性患者中使用。它们能延缓复发并减少复发次数，对于局限性乳腺癌，生存率的提高尤为显著。它们还能加强局部治疗并增加保乳的可能性。通过对预后因素，尤其是肿瘤细胞进行精确分析，可以更好地确定其适用症。
